$259.02
0.26%
NYSE, Nov 19, 04:00 pm EST. Closed.
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$259.09
+24.18 10.29% 1M
+68.70 36.08% 6M
+85.56 49.31% YTD
+73.13 39.33% 1Y
+124.24 92.13% 3Y
+110.65 74.54% 5Y
+171.80 196.82% 10Y
+206.29 390.70% 20Y
NYSE, Closing price Thu, Nov 19 2026
-0.60 0.23%

AI Insights on Quest Diagnostics Insights AI Insights on Quest Diagnostics

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$28.6b
Enterprise Value
$33.3b
Net debt
$4.8b
Cash
$797.0m
Shares outstanding
110.0m
Valuation
P/E
25.9
P/S | estimate
2.4 | 2.3
EV/Sales | estimate
2.8 | 2.7
EV/FCF | ex SBC
24.2 | 25.9
P/B
3.7
Dividends
DPS
$3.44
Yield 1Y | 5Y
1.3% | 1.9%
Growth 1Y | 5Y
7.5% | 6.8%
Payout 1Y | 3Y
36.6% | 37.8%
Increased
16 Years
Financials
Revenue | estimate
$11.8b | $12.2b
EBITDA
$1.9b
EBIT
$1.8b
Net Income
$1.1b
Free Cash Flow | ex SBC
$1.4b | $1.3b
Growth
Revenue | estimate
9.1% | 10.6%
EBITDA
9.3%
EBIT
10.5%
Net Income
16.8%
Free Cash Flow
-1.3%
Margin
Gross
33.2%
EBITDA
16.2%
EBIT
14.9%
Net
9.5%
Free Cash Flow | ex SBC
11.6% | 10.9%
Financial Health
Equity Ratio
44.2%
Return on Equity
13.8%
ROCE
11.5%
ROIC
-
Debt/Equity
0.7
Share-Based Compensation & Dilution
SBC | % of Revenue
$88.0m | 0.7%
SBC as % of FCF
6.4%
SBC Growth 1Y
-2.2%
Share Count Growth 1Y
-0.9%
Shareholder Yield
2.2%
More
EPS
$10.0
FCF per Share
$12.5
Short interest
3.4%
Employees
52k
Rev per Employee
$210.0k

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Quest Diagnostics forecast:

12x Buy
52%
11x Hold
48%

Analyst Opinions

23 Analysts have issued a Quest Diagnostics forecast:

Buy
52%
Hold
48%

Quest Diagnostics Events

Past Events
NOV
17
Jefferies London Healthcare Conference
3 days ago
OCT
22
Q3 2026 Earnings Call
29 days ago
SEP
15
2026 Global Healthcare Conference
2 months ago
SEP
14
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
JUL
23
Q2 2026 Earnings Call
4 months ago
APR
21
Q1 2026 Earnings Call
7 months ago
MAR
11
Leerink Global Healthcare Conference 2026
8 months ago
FEB
10
Q4 2025 Earnings Call
9 months ago
JAN
12
44th Annual J.P. Morgan Healthcare Conference
10 months ago
DEC
2
Citi Annual Global Healthcare Conference 2025
12 months ago
NOV
14
7th Annual Healthcare Symposium
about one year ago
OCT
21
Q3 2025 Earnings Call
about one year ago

Financial data from Quest Diagnostics

Sep '26
+/-
%
11,841 11,841
9% 9%
100%
- Direct Costs 7,913 7,913
10% 10%
67%
3,928 3,928
8% 8%
33%
- Selling and Administrative Expenses 2,025 2,025
6% 6%
17%
- Research and Development Expense - -
-
-
1,913 1,913
9% 9%
16%
- Depreciation and Amortization 149 149
3% 3%
1%
EBIT (Operating Income) EBIT 1,764 1,764
11% 11%
15%
Net Profit 1,125 1,125
17% 17%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
PRNewsWire
●
9 days ago
SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record of Quest Diagnostics common stock on January 12, 2027.
Neutral
PRNewsWire
●
10 days ago
SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference in Miami on Tuesday, December 1, 2026, at 2:10 p.m.
Positive
Market Watch
●
20 days ago
Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? Companies like Johnson & Johnson, Quest Diagnostics and UnitedHealth Group have long been known for producing steady results, driven by patient demand and government reimbursement.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO Mr. Davis
Employees 51,500
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today